Becton Dickinson & Co. closed 32.13% below its 52-week high of $251.99, which the company reached on February 3rd.

Becton, Dickinson and Company ( NYSE: BDX) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ET Tom Polen - Chairman, Chief Executive Officer and President ...

Even though Becton, Dickinson and Company (NYSE:BDX) posted strong earnings, investors appeared to be underwhelmed. We have done some analysis and have found some comforting factors beneath the ...

Shares of Becton Dickinson & Co. BDX advanced 4.86% to $175.34 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 3.26% to ...

Tuesday  announced the global commercial launch of the world's first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies.

The most notable increase was in Becton Dickinson & Co (NYSE:BDX), with an additional 1,091,690 shares, bringing the total to 5,517,712 shares. This adjustment represents a significant 24.67% ...

Analysts are intrested in these 5 stocks: ( ($BDX) ), ( ($SPOT) ), ( ($ARVN) ), ( ($TWLO) ) and ( ($LUMN) ). Here is a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The most notable increase was in Becton Dickinson & Co (NYSE:BDX), with an additional 1,091,690 shares, bringing the total to 5,517,712 shares. This adjustment represents a significant 24.67% increase ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...